Firm promoting its longest-marketed brand, which accounts for 40% of revenues and includes oral and personal care lines as well as household products, with “Give it the Hammer” campaign.

“You won't be seeing us buying devices in the future,” says CEO Matthew Farrell. Acquisitions won’t have lower profile in growth strategy and it’s investing behind boosting returns from its most recent additions, acne patch firm Hero Cosmetics and TheraBreath mouthwashes, toothpastes and lozenges.

Sales in most categories in US portfolio grew, led by Zicam, Therabreath and Hero. But slumps continued for Waterpik water flossers, the Flawless feminine hair-removal, skin and nail care line and the vitafusion and L’il Critter gummies and other vitamin, mineral and supplement products.

Demand for OTC pain relievers and cough/cold products jumped prior to October-December and remained high during quarter due to consumer concern not only about flu but also RSV and additional COVID-19 mutation. US and Canadian firms marketing OTC drugs and supplements also will be offering additional signals on planned spinoffs of consumer health businesses.